Rapid warfarin reversal: combination of a 3-factor prothrombin complex concentrate and low dose recombinant FVIIa for traumatic intracranial hemorrhage

被引：0
|
作者：
Cusick, Robin M. [1 ]
Matevosyan, Karen [1 ]
Aung, Fleur [1 ]
Madden, Christopher [2 ]
Chason, David [3 ]
Arbique, Gary [3 ]
Guild, Jeffrey [3 ]
Shafi, Shahid [4 ]
Sarode, Ravindra [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Neurosurg, Dallas, TX 75390 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA
[4] Univ Texas SW Med Ctr Dallas, Dept Trauma, Dallas, TX 75390 USA
来源：
HAEMOPHILIA | 2009年 / 15卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：630 / 630
页数：1
相关论文
共 50 条
  • [31] Treatment of Warfarin-Related Intracranial Hemorrhage: A Comparison of Prothrombin Complex Concentrate and Recombinant Activated Factor VII
    Pinner, Nathan A.
    Hurdle, April C.
    Oliphant, Carrie
    Reaves, Anne
    Lobo, Bob
    Sills, Allen
    WORLD NEUROSURGERY, 2010, 74 (06) : 631 - 635
  • [32] Dosing of 3-Factor Prothrombin Complex Concentrate for International Normalized Ratio Reversal
    Baggs, Jennifer H.
    Patanwala, Asad E.
    Williams, Evan M.
    Erstad, Brian L.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (01) : 51 - 56
  • [33] Low-dose versus standard-dose four-factor prothrombin complex concentrate for factor-Xa inhibitor reversal in spontaneous and traumatic intracranial hemorrhage
    Cascone, Ava E.
    Daley, Mitchell J.
    Pan, Neil
    Padilla-Tolentino, Eimeira
    Milling, Truman J.
    PHARMACOTHERAPY, 2021, 41 (06): : 501 - 507
  • [34] High-Dose 4-Factor Prothrombin Complex Concentrate for Warfarin-Induced Intracranial Hemorrhage
    Merchan, Cristian
    Ahuja, Tania
    Raco, Veronica
    Lewis, Ariane
    NEUROHOSPITALIST, 2020, 10 (01): : 16 - 21
  • [35] Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage
    Denise H. Rhoney
    Mary La
    Molly Merz
    Aaron Cook
    Kent A. Owusu
    Christina Roels
    Joe Blunck
    Justin Shewmaker
    Kiranpal S. Sangha
    Salia Farrokh
    John Lewin
    Kathleen W. Chester
    Theresea Human
    Kathleen Bledsoe
    Kristy Greene
    Melissa Levesque
    Jody C. Rocker
    Gary Davis
    Ron Neyens
    Timothy F. Lassiter
    Sarah M. Adriance
    Neurocritical Care, 2021, 35 : 130 - 138
  • [36] Rapid Reversal of Warfarin using Immediate Release of Fixed Low-dose Four-factor Prothrombin Complex Concentrate
    Fayyaz, K.
    TRANSFUSION, 2016, 56 : 174A - 174A
  • [37] Traumatic intracranial hemorrhage in the setting of 4-factor prothrombin complex concentrate
    Mushlin, Harry
    Mushlin, Harry
    Cunnion, Mary
    Hines, Michele
    Kufera, Joseph
    Pajoumand, Mehrnaz
    Aarabi, Bizhan
    Stein, Deborah
    JOURNAL OF NEUROSURGERY, 2018, 128 (04) : 55 - 56
  • [38] Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage
    Rhoney, Denise H.
    La, Mary
    Merz, Molly
    Cook, Aaron
    Owusu, Kent A.
    Roels, Christina
    Blunck, Joe
    Shewmaker, Justin
    Sangha, Kiranpal S.
    Farrokh, Salia
    Lewin, John
    Chester, Kathleen W.
    Human, Theresea
    Bledsoe, Kathleen
    Greene, Kristy
    Levesque, Melissa
    Rocker, Jody C.
    Davis, Gary
    Neyens, Ron
    Lassiter, Timothy F.
    Adriance, Sarah M.
    NEUROCRITICAL CARE, 2021, 35 (01) : 130 - 138
  • [39] A COMPARISON OF 3-FACTOR PROTHROMBIN COMPLEX CONCENTRATE PRODUCTS IN WARFARIN-ASSOCIATED ICH
    Tucker, Natalie
    Cook, Ryan
    Cave, Brandon
    Jones, Morgan
    CRITICAL CARE MEDICINE, 2020, 48
  • [40] High-dose versus low-dose 4-factor prothrombin complex concentrate for factor Xa inhibitor reversal in intracranial hemorrhage
    Davis, Spencer D.
    Chauv, Stephanie
    Hickman, Abby W.
    Collingridge, Dave S.
    Kjerengtroen, Sara
    Fontaine, Gabriel, V
    THROMBOSIS RESEARCH, 2021, 208 : 112 - 116
12345